Bruno Vellas Selected Research

Caloric Restriction

1/2016	Caloric restriction and aerobic exercise in sarcopenic and non-sarcopenic obese women: an observational and retrospective study.
3/2013	Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.
11/2008	Caloric restriction and brain function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Vellas Research Topics

Disease

138	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 12/2002
80	Dementia (Dementias) 01/2024 - 04/2003
73	Cognitive Dysfunction 03/2024 - 12/2003
31	Frailty 11/2023 - 06/2013
20	Inflammation (Inflammations) 01/2024 - 11/2005
16	Weight Loss (Weight Reduction) 10/2023 - 10/2002
15	Sarcopenia 01/2024 - 08/2003
14	Atrophy 01/2021 - 01/2008
13	Disease Progression 11/2022 - 12/2003
10	Pneumonia (Pneumonitis) 01/2022 - 09/2013
7	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 01/2012
7	Malnutrition (Nutritional Deficiencies) 10/2023 - 06/2009
7	Osteoporosis 07/2015 - 04/2005
6	Hypertension (High Blood Pressure) 01/2024 - 11/2012
5	Obesity 01/2022 - 08/2006
5	Fatigue 06/2021 - 03/2014
4	Stroke (Strokes) 01/2024 - 12/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2009
4	Edema (Dropsy) 01/2023 - 01/2012
4	Amyloid Plaque 11/2022 - 11/2005
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 11/2008
4	Infections 11/2020 - 01/2009
4	Pain (Aches) 01/2019 - 01/2007
3	Heart Failure 01/2024 - 12/2013
3	Chronic Disease (Chronic Diseases) 01/2023 - 11/2012
3	Body Weight (Weight, Body) 01/2023 - 10/2004
3	Neuroinflammatory Diseases 01/2022 - 12/2019
3	Atrial Fibrillation 01/2021 - 12/2013
3	Drug-Related Side Effects and Adverse Reactions 01/2017 - 05/2010
2	Genomic Instability 01/2023 - 11/2022
2	Neoplasms (Cancer) 01/2022 - 09/2013
2	Brain Diseases (Brain Disorder) 01/2021 - 10/2012
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2020 - 05/2011

Drug/Important Bio-Agent (IBA)

67	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2007
42	Amyloid (Amyloid Fibrils)IBA 03/2024 - 01/2012
22	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2011
17	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2010
12	Amyloid beta-PeptidesIBA 01/2023 - 09/2007
12	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015 - 10/2003
11	Vitamin D FDA LinkGeneric 01/2024 - 01/2009
9	LipidsIBA 01/2024 - 01/2014
9	ApolipoproteinsIBA 01/2023 - 01/2010
6	Interleukin-6 (Interleukin 6)IBA 01/2024 - 08/2006
6	Growth Differentiation Factor 15IBA 10/2023 - 01/2022
6	HomocysteineIBA 01/2023 - 01/2010
6	Antipsychotic Agents (Antipsychotics)IBA 06/2019 - 05/2011
6	Indicators and Reagents (Reagents)IBA 01/2018 - 08/2003
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2024 - 03/2013
5	Peptides (Polypeptides)IBA 05/2023 - 01/2012
5	C-Reactive ProteinIBA 01/2023 - 01/2019
5	ProgranulinsIBA 01/2023 - 01/2022
5	verubecestatIBA 12/2020 - 01/2018
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2020 - 02/2011
5	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2016 - 01/2010
5	Donepezil (Aricept)FDA LinkGeneric 03/2011 - 12/2002
4	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 08/2006
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023 - 01/2022
4	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 02/2015
4	CytokinesIBA 01/2022 - 01/2011
4	Antidepressive Agents (Antidepressants)IBA 01/2021 - 02/2010
4	florbetapirIBA 10/2018 - 01/2017
4	Memantine (Namenda)FDA Link 11/2011 - 01/2004
3	Cholecalciferol (Vitamin D3)FDA Link 01/2024 - 11/2020
3	Monoclonal AntibodiesIBA 01/2023 - 01/2012
3	Pemetrexed (MTA)FDA Link 12/2020 - 01/2008
3	Cholinergic Agents (Cholinergics)IBA 01/2018 - 11/2005
3	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2017 - 01/2014
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2015 - 01/2010
3	MicronutrientsIBA 01/2015 - 03/2013
3	Blood Proteins (Serum Proteins)IBA 11/2014 - 07/2010
3	Ginkgo biloba extract (Rokan)IBA 10/2012 - 04/2003
3	Rivastigmine (Exelon)FDA LinkGeneric 03/2011 - 10/2003
3	Galantamine (Galanthamine)FDA LinkGeneric 03/2011 - 01/2004
3	strontium ranelate (protelos)IBA 02/2011 - 07/2006
2	Triglycerides (Triacylglycerol)IBA 03/2024 - 09/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2024 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 11/2022
2	Adenosine Triphosphatases (ATPase)IBA 10/2023 - 01/2023
2	Eicosapentaenoic AcidIBA 01/2023 - 01/2015
2	Docosahexaenoic AcidsIBA 01/2023 - 01/2015
2	gantenerumabIBA 11/2022 - 08/2012
2	CholesterolIBA 01/2022 - 09/2014
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2022 - 01/2017
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 01/2017
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2020 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 02/2011
2	lanabecestatIBA 11/2020 - 01/2020

Therapy/Procedure

38	Activities of Daily Living (ADL) 01/2024 - 06/2003
26	Home Nursing (Nursing, Home) 01/2022 - 02/2007
18	Therapeutics 01/2023 - 12/2003
11	Institutionalization (Institutionalized Persons) 01/2018 - 08/2005
8	Polypharmacy 01/2022 - 06/2009
7	Long-Term Care 12/2018 - 09/2003
6	Patient Care 01/2018 - 01/2013
4	Resistance Training 11/2020 - 05/2011
4	Secondary Prevention 10/2020 - 05/2008
3	Immunotherapy 01/2024 - 01/2012
3	Drug Prescriptions 01/2019 - 05/2012
3	Caloric Restriction 01/2016 - 11/2008
2	Precision Medicine 01/2021 - 11/2019